14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.98 $159.34 Friday, 3rd May 2024 ALNY stock ended at $152.33. This is 1.34% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.30% from a day low at $151.91 to a day high of $155.41.
90 days $141.98 $173.18
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Jun 18, 2020 $136.94 $142.29 $136.94 $141.99 918 478
Jun 17, 2020 $132.88 $138.26 $132.88 $136.67 1 601 737
Jun 16, 2020 $130.15 $132.52 $128.32 $132.26 413 528
Jun 15, 2020 $123.17 $130.04 $120.82 $128.38 597 506
Jun 12, 2020 $127.41 $127.99 $120.05 $125.39 832 855
Jun 11, 2020 $128.16 $130.92 $125.00 $125.91 809 666
Jun 10, 2020 $130.55 $132.57 $127.67 $129.71 599 289
Jun 09, 2020 $130.17 $132.27 $128.32 $129.79 532 815
Jun 08, 2020 $128.50 $131.14 $123.98 $130.44 611 646
Jun 05, 2020 $131.01 $132.60 $127.34 $127.59 610 762
Jun 04, 2020 $137.06 $139.03 $131.11 $131.90 622 341
Jun 03, 2020 $138.81 $138.81 $134.02 $137.25 551 133
Jun 02, 2020 $130.68 $139.19 $130.68 $138.82 548 824
Jun 01, 2020 $135.12 $136.63 $131.33 $133.57 559 999
May 29, 2020 $134.59 $135.32 $129.56 $135.27 868 631
May 28, 2020 $135.26 $136.14 $132.47 $133.10 578 056
May 27, 2020 $134.14 $134.14 $126.24 $133.35 853 318
May 26, 2020 $141.06 $144.50 $135.80 $136.43 784 612
May 22, 2020 $141.61 $142.35 $138.21 $140.52 775 950
May 21, 2020 $142.78 $144.22 $140.44 $141.86 667 424
May 20, 2020 $143.78 $145.08 $141.27 $143.45 737 404
May 19, 2020 $145.24 $146.77 $142.18 $142.41 484 768
May 18, 2020 $143.64 $145.82 $141.29 $144.87 617 284
May 15, 2020 $136.52 $139.60 $135.31 $139.28 756 097
May 14, 2020 $134.63 $138.00 $133.42 $136.20 935 058
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT